Statistics from Altmetric.com
Many randomised double-blind short-term growth studies have been performed in the last two decades showing that inhaled glucocorticoids are associated with a significant risk of dose-related growth suppression in prepubertal children.1–⇓3 Despite having been on the market since the early 1980s for use in children, the potential of inhaled glucocorticoids for suppression of final height, however, has not yet been clarified. This study aimed to answer the question: what happens to adult height in children who present a growth deficit caused by few years’ treatment with inhaled glucocorticoids in childhood?
This study was an open, observational 8-year follow-up of a principal randomised, …
Competing interests None.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.